Bone Pain clinical trials

Explore recruiting bone pain clinical trials.

Recruiting bone pain studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Bone Pain trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Treatment of Osteogenesis Imperfecta with Parathyroid hormone and Zoledronic acid

France, Ireland, Netherlands, Denmark

Therapeutic use (Phase IV) EU CTIS Study details

MetAddon: Methadone as co-analgesic for patients with metastatic bone pain: a double-blind randomized controlled trial

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Multicentre, randomized, controlled, open-label, multi-centre medicoeconomic study evaluating the efficacy of adding zoledronic acid or denosumab to Stereotaxic radiotherapy in the treatment of vertebral metastases (ZOSTER)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

EORTC 2237-BCG-QLG: Improvement of Quality of Life through supportive treatments for Endocrine Therapy – related symptoms in patients with early Breast cancer; A pragmatic randomized Controlled Trial (QOL-ET-BC)

Spain, Slovenia, Poland, France, Cyprus

Therapeutic confirmatory (Phase III) EU CTIS Study details

Randomized, multicentre phase II trial of the sequencing of Radium-223 and Docetaxel plus prednisone in symptomatic bone-only metastatic castration-resistant prostate cancer (mCRPC)

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

TulmiSTAR-02: A two-part Phase I dose escalation study of tulmimetostat (DZR123) in combination with darolutamide or abiraterone followed by open-label, randomized, Phase II dose expansion study to assess the safety and efficacy of tulmimetostat in combination with darolutamide versus darolutamide alone in patients with metastatic hormone-sensitive prostate cancer

Hungary, Spain, Italy, Germany, France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Bone Pain trials by city

Bone Pain in Toronto Bone Pain in Vancouver Bone Pain in Montreal Bone Pain in Calgary Bone Pain in Edmonton Bone Pain in Ottawa Bone Pain in Winnipeg Bone Pain in Quebec City Bone Pain in Hamilton Bone Pain in Kitchener Bone Pain in London Bone Pain in Halifax Bone Pain in New York Bone Pain in Los Angeles Bone Pain in Chicago Bone Pain in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease